1 / 12

Camp Lejeune Cancer Incidence Study (CIS): A retrospective cohort study

Camp Lejeune Cancer Incidence Study (CIS): A retrospective cohort study. Frank J. Bove, Sc.D , MS. Agency for Toxic Substances and Disease Registry (ATSDR)/ Centers for Disease Control and Prevention (CDC) NAACCR/IACR Combined Annual Conference, June 13, 2019.

clea
Télécharger la présentation

Camp Lejeune Cancer Incidence Study (CIS): A retrospective cohort study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Camp Lejeune Cancer Incidence Study (CIS):A retrospective cohort study Frank J. Bove, Sc.D, MS Agency for Toxic Substances and Disease Registry (ATSDR)/ Centers for Disease Control and Prevention (CDC) NAACCR/IACR Combined Annual Conference, June 13, 2019 Agency for Toxic Substances and Disease Registry

  2. Researchers Principal Investigator: Frank J. Bove, ScD, MS Agency for Toxic Substances and Disease Registry (ATSDR) / Centers for Disease Control and Prevention (CDC) Contractor: Battelle Memorial Institute • Project Director: April Greek, PhD • Project Manager: Ruth Gatiba, MPH

  3. Researchers Subcontractors: • North American Association of Central Cancer Registries • Assistant Project Director: Betsy Kohler, MPH, CTR • Recinda Sherman, MPH, PhD, CTR • Castine Clerkin, MS, CTR • Information Management Services, Inc. (IMS) • Donald Green, BS • William Howe, BS, BA • University of Southern California –Los Angeles • Rich Pinder, BA • Dennis Deapen, PhD

  4. Objectives • Determine if exposures of marines and civilian workers to contaminated drinking water at Camp Lejeune were associated with increased risks of cancers. • Did Camp Lejeune marines and workers have higher incidence rates for cancers than comparison cohorts of marines and workers? • Within the Camp Lejeune cohorts, were there exposure-response relationships between cumulative exposures to the drinking water contaminants and increased incidence rates of cancers?

  5. Cohorts • Marine/Navy personnel, 1975 - 1987 (N=521,154) • Camp Lejeune = 241,513 • Camp Pendleton = 256,697 • New River Air Station = 22,944 • Civilian employees, 1972 – 1987 (N=15,447) • Camp Lejeune = 8,024 • Camp Pendleton = 7,423

  6. Information Sources • Defense Manpower Data Center personnel records • Social security number, name, date of birth, sex, race, unit code, base location • Camp Lejeune base family housing data • Locator firm (TransUnion), Social Security Administration (SSA) data, and the National Death Index (NDI) • Vital status, current address, state and date of death

  7. Cancer registry data • Veterans Affairs Central Cancer Registry, Department of Defense Automated Central Tumor Registry, state and territorial cancer registries • Cancer incidence data linked to personal identifier information

  8. Why national data? • Camp Lejeune and Camp Pendleton cohorts reside in all 50 states and U.S. territories • To minimize bias, registry data must be available for a high percentage (e.g., >90%) of both cohorts • Comprehensive case ascertainment necessary for adequate statistical power since many cohort members will be <65 years old at end of follow-up

  9. Analyses • Comparisons between Camp Lejeune and Camp Pendleton cohorts • January 1996 – December 2017 • Comparisons internal to Camp Lejeune cohorts • As far back as registry has complete data or January 1973, whichever is later, through December 2017

  10. Progress to date • Applications submitted to 51 cancer registries • Full approval received from 49 registries: • 45 state registries • VACCR, D.C., Puerto Rico, Pacific Island Jurisdiction

  11. Next steps • Obtain study approvals from remaining registries • Obtain data security agreements and other materials from each registry prior to participation in the linkage • Finalize agreements with TransUnion, SSA, and NDI to obtain current address and vital status information • Each cancer registry performs linkage with cohort data

  12. Questions?

More Related